Accelr8 Technology Corporation (AXK) Names Dr. Matthew Strobeck to Board of Directors  
7/11/2012 10:13:17 AM

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Mkt: AXK), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Dr. Matthew Strobeck has been appointed to Accelr8's Board of Directors.